Le Lézard
Classified in: Environment, Science and technology
Subjects: PER, RCY, ANW

Salvatore Zizza Named to Bion's Board of Directors

NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment technology and premium sustainable beef, announced today that Salvatore Zizza will join Bion's Board of Directors, effective February 15, 2023.

As a Board member, Mr. Zizza brings decades of experience in institutional finance, commerce, and public company practices. In addition to serving as an independent Board Member, Mr. Zizza will help implement governance procedures that include establishing and chairing the Audit Committee (and other committees) that will be set up during the next 30-60 days so that Bion meets the requirements of a listing on a national exchange.

Mr. Zizza is currently a Director of 19 funds in the Gabelli Asset Management and GAMCO Investors, Inc. fund families, including several that trade on the NYSE. He serves as Chairman of Bergen Cove Realty Inc., with substantial holdings in residential real estate, and as Director and Chairman of Trans-Lux Corporation, a full-service provider of integrated multimedia systems for today's communications environments.

Mr. Zizza is a retired Chairman of BAM, an advanced material science company that provides carbonization, graphitization, pyrolysis, carbon vapor deposition, and other high temperature processing services for semiconductor, aerospace, military, environmental, and other specialized applications. From 1985 to 1997, he was Chairman and CEO of the LVI Group, Inc., an NYSE-listed firm. Mr. Zizza previously served Bion in a senior management role between 2005 and 2008.

Mr. Zizza said, "I am excited to return and help Bion achieve success, not just for its shareholders, but also livestock producers, the consumer, and the planet. My hat is off to the Bion team, both for their vision and perseverance. The timing of the Gen3Tech system development coincides with a growing awareness of the need for all industries to reduce their carbon and pollution footprints and improve overall sustainability.  I look forward to contributing to those efforts by expanding the experience and expertise of the Board of Directors as the company positions itself for growth."

Bill O'Neill said, "We are glad to add Sal's wide-ranging corporate experience to our team as we move forward with commercialization of our technology and business model. We expect his institutional background to prove invaluable as we begin to structure, finance, and develop the large-scale joint ventures that will be required to deliver true sustainability to the beef and livestock industries."

About Bion: Bion's patented third generation technology (Gen3Tech) was designed to largely mitigate the environmental impacts of large-scale livestock production, increase its resource efficiencies, and deliver a USDA-certified sustainable product to the consumer. The platform simultaneously prevents pollution to air, water, and soil, while recovering high-value organic fertilizer coproducts and renewable energy that increase revenues. Bion's Gen3Tech platform can create a pathway to true economic and environmental sustainability with 'win-win' benefits for a premium sector of the $175 billion U.S. livestock industry and the consumer. For more information, see Bion's website at https://bionenviro.com.  

This material includes forward-looking statements based on management's current reasonable business expectations. In this document, the words 'will', 'expect', 'look forward (to)', and similar expressions identify certain forward-looking statements. These statements are made in reliance on the Private Securities Litigation Reform Act, Section 27A of the Securities act of 1933, as amended. There are numerous risks and uncertainties that could result in actual results differing materially from expected outcomes.

SOURCE Bion Environmental Technologies, Inc.

These press releases may also interest you

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

News published on and distributed by: